Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters









Database
Language
Publication year range
1.
Antileukemic effect of L-aspartyl-hydrazine.
Stern, P; Valjevac, K; Balenovic, K.
Neoplasma ; 22(1): 69-71, 1975.
Article in English | MEDLINE | ID: mdl-1153038

ABSTRACT

Beta-L-aspartyl-hydrazine can significantly prolong survival of the A mouse strain infected with a lymphatic leukemia sensitive to L-asparaginase. By combining the above substance with L-asparaginase even better results can be obtained.


Subject(s)
Aspartic Acid/analogs & derivatives , Hydrazines/therapeutic use , Leukemia, Lymphoid/drug therapy , Animals , Asparaginase/administration & dosage , Asparaginase/therapeutic use , Aspartic Acid/administration & dosage , Aspartic Acid/therapeutic use , Carcinoma, Ehrlich Tumor/drug therapy , Hydrazines/administration & dosage , Leukemia, Experimental , Mice , Sarcoma 180/drug therapy
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL